Home - St. Luke's Hospital
Letter from Dr. Van Amburg

Primary Site Analysis

Trilogy™ Stereotactic System offers image-guided treatment for patients

Da Vinci® Robotic Surgical System offers faster recovery for patients

St. Luke's first to offer new cancer diagnosing technology to women with dense breasts

Breast care coordinators help patients navigate complexities following diagnosis

Research cures cancer

Community support and screenings

Palliative care helps comfort patients

Hospice provides care when it's needed most

Patient treatment analysis of prostate brachytherapy

Surgical treatment of prostate cancer

From our patients

Physician Members

Ex Officio Physician Members

Ancillary Members

Back to Main Site
St. Luke's first to offer new cancer diagnosing technology to women with dense breasts
St. Luke's Hospital was the first facility in St. Louis and the second in the United States to be accredited in mammography by the American College of Radiology (ACR). St. Luke's is also designated a Breast Imaging Center of Excellence by the ACR for excellence in breast imaging. In keeping with being on the leading edge of cancer discovery and treatment, St. Luke's also became the first hospital in Missouri to offer the SonoCin� breast ultrasound exam to patients with dense breasts.

According to research, two out of five women have dense breast tissue. Researchers have found that breast density is a predictor of increased risk for developing breast cancer. Women with dense breasts have a four-to-six times higher risk of developing breast cancer compared to women with less dense breasts.

This density can also make finding abnormalities in the breast difficult since both dense areas and tumors show up white on a mammogram. Women with dense breasts can now consider adding the SonoCin� exam to their yearly mammograms. The SonoCin� exam is not a substitution for screening mammography.

SonoCin� is an automated whole breast ultrasound (AWBU) exam that, when added to an annual mammogram, may find additional and smaller cancers than mammography alone. The SonoCin� exam is also computer-guided, requires no breast compression or injections and is permanently recorded for physician review and follow-up.

A study recently published in the journal European Radiology reported the benefits of adding the SonoCin� exam to a standard mammogram. In 6,425 cases, it found that breast cancer detection doubled from 23 cancers discovered by mammography alone to 46 using AWBU along with mammography. In addition, the number of detected invasive cancers 10 millimeters or less in size tripled from 7 to 21 when AWBU findings were added to mammography. The study concluded that AWBU resulted in significant cancer detection improvement compared with mammography alone in women with dense breast tissue.

"SonoCin� is literally a lifesaver and a welcome addition to our diagnostic tools for women," says Carrie Morrison, MD, director of Breast Imaging at St. Luke's. "Finding cancers early will help us save countless lives and bring more confidence to those receiving care."

Center for Cancer Care | Home - St. Luke's Hospital

232 South Woods Mill Road - Chesterfield, MO 63017 - 314-434-1500
© St. Luke's Hospital
Website Privacy Policy | Website Terms and Conditions
Patient Notice of Privacy Policies (PDF)